Citigroup’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $68K | Sell |
|
|||||
|
2022
Q1 | $281K | Sell |
|
|||||
|
2021
Q4 | $2.77M | Buy |
|
|||||
|
2021
Q3 | $2.07M | Sell |
|
|||||
|
2021
Q2 | $4M | Buy |
|
|||||
|
2021
Q1 | $4.84M | Buy |
|
|||||
|
2020
Q4 | $116K | Sell |
|
|||||
|
2020
Q3 | $162K | Sell |
|
|||||
|
2020
Q2 | $1.25M | Buy |
|
|||||
|
2020
Q1 | $912K | Buy |
|
|||||
|
2019
Q4 | $1.11M | Buy |
|
|||||
|
2019
Q3 | $239K | Sell |
|
|||||
|
2019
Q2 | $5.57M | Buy |
|
|||||
|
2019
Q1 | $505K | Sell |
|
|||||
|
2018
Q4 | $6.57M | Buy |
|
|||||
|
2018
Q3 | $2.54M | Buy |
|
|||||
|
2018
Q2 | $665K | Sell |
|
|||||
|
2018
Q1 | $7.38M | Buy |
|
|||||
|
2017
Q4 | $4.02M | Sell |
|
|||||
|
2017
Q3 | $23.5M | Sell |
|
|||||
|
2017
Q2 | $26.9M | Sell |
|
|||||
|
2017
Q1 | $27.2M | Buy |
|
|||||
|
2016
Q4 | $11M | Buy |
|
|||||
|
2016
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $700K | Buy |
|
|||||
|
2015
Q4 | $264K | Sell |
|
|||||
|
2015
Q3 | $5.5M | Buy |
|
|||||
|
2015
Q2 | $1.92M | Sell |
|
|||||
|
2015
Q1 | $2.52M | Buy |
|
|||||
|
2014
Q4 | $859K | Buy |
|
|||||
|
2014
Q3 | $648K | Buy |
|
|||||
|
2014
Q2 | $323K | Sell |
|
|||||
|
2014
Q1 | $573K | Sell |
|
|||||
|
2013
Q4 | $658K | Buy |
|
|||||
|
2013
Q3 | $652K | Buy |
|
|||||
|
2013
Q2 | $21K | Buy |
|